Qulipta 00074-7096-04

Generic: Atogepant

Package NDC

00074-7096-04

Manufacturer: Abbvie Inc.
Dosage Form: Tablet
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: September 30, 2021
Listing Expires: December 31, 2027
Application: NDA215206

Need to source Qulipta? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Atogepant	30 mg/1

Drug Class

Calcitonin Gene-related Peptide Receptor Antagonist [EPC]Calcitonin Gene-related Peptide Receptor Antagonist [EPC]Calcitonin Gene-related Peptide Receptor Antagonists [MoA]

Selected Package

00074-7096-04Selected

4 TABLET in 1 BOTTLE (0074-7096-04)

Other packages for this product(2)

00074-7096-30

30 TABLET in 1 BOTTLE (0074-7096-30)

View →

00074-7096-70

4 TABLET in 1 BOTTLE (0074-7096-70)

View →